BioMarin Pharmaceutical Inc. will pay a premium of approximately $840 million to buy Prosena Holding N.V. (Nasdaq: RNA) sending the stock price leaping $7.16 to close at $18.60.
Prosena to be acquired
November 24, 2014 at 15:55 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.